Management of oral bleeding in haemophilic patients.
Baudo
F
F
deCataldo
F
F
Landonio
G
G
Muti
G
G
D007611:Aprotinin / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005176:Factor XIII / Q000627:therapeutic use*; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications*; D006801:Humans; D006472:Oral Hemorrhage / Q000188:drug therapy*; D013917:Thrombin / Q000627:therapeutic use*; D014014:Tissue Adhesives / Q000627:therapeutic use*; D014081:Tooth Extraction / Q000009:adverse effects*; D014148:Tranexamic Acid / Q000627:therapeutic use*
D003509:Cyclohexanecarboxylic Acids; D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives; D014148:Tranexamic Acid; D005340:Fibrinogen; D005176:Factor XIII; D007611:Aprotinin; D013917:Thrombin